Purdue Pharma director grilled on proposed opioid settlement

0
106

NEW YORK (AP) — Purdue Pharma’s quest to settle thousands of lawsuits over OxyContin’s toll has entered its final phase with the grudging acceptance of most of those who have claims against the company. A confirmation hearing opened in U.S. Bankruptcy Court on Thursday for a deal that removes control of the company from members of the wealthy Sackler family and requires them to contribute $4.5 billion to opioid abatement. While most states have come to support the plan, a lawyer representing Connecticut grilled a company board member over whether states should be able to pursue lawsuits against the Sacklers instead.

The post Purdue Pharma director grilled on proposed opioid settlement appeared first on WEEK.

LEAVE A REPLY

Please enter your comment!
Please enter your name here